Concept information
Preferred term
Razoxane
Type
-
mesh:Descriptor
Definition
- An antimitotic agent with immunosuppressive properties.
Broader concept
Narrower concepts
Synonym(s)
- 21416-67-1 (cpd without isomeric designation)
- 21416-87-5 (Razoxane)
- 24613-06-7 ((R)-isomer)
- 2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (+-)-
- 5AR83PR647
- 79703-22-3 ((R)-isomer, mesylate)
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (+-)-
-
21416-67-1 (cpd without isomeric designation)
-
21416-87-5 (Razoxane)
-
24613-06-7 ((R)-isomer)
-
5AR83PR647
-
79703-22-3 ((R)-isomer, mesylate)
URI
http://data.loterre.fr/ark:/67375/JVR-N172S381-F
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}